In conversation with Medtronic’s Frank Chan, head of its off-again, on-again acute care and monitoring division

Fierce Biotech March 12, 2024
Conor Hale

Once slated to either strike out on their own or be the subject of a potential sale, Medtronic’s patient monitoring and respiratory intervention divisions will see new life after merging into a single multibillion-dollar arm dubbed acute care and monitoring.

The medtech giant announced the reversal of its spinoff strategy late last month after more than a year of planning. Previously, the company said the move would help it focus investments on other priorities, including in cardiovascular devices, neuroscience and surgery.

But, now, Medtronic is pointing toward the importance of data—which is, of course, generated in massive amounts by ACM’s 8,000-odd workers and its portfolio of patient monitoring devices, pulse oximeters, telehealth platforms and other technologies.

However, not...

Today's Sponsors

Today's Sponsor